ChemicalBook >> CAS DataBase List >>MOXISYLYTE

MOXISYLYTE

CAS No.
54-32-0
Chemical Name:
MOXISYLYTE
Synonyms
sympal;opilon;Vasoklin;arlytene;moxilite;moxisylyt;moxisylyte;timoxamina;thymoxamine;THYMOXAMINE HCL
CBNumber:
CB5506264
Molecular Formula:
C16H25NO3
Molecular Weight:
279.37
MDL Number:
MFCD00868265
MOL File:
54-32-0.mol
Last updated:2023-05-04 17:34:39

MOXISYLYTE Properties

storage temp. 2-8°C
FDA UNII PW8QYA7KI0
ATC code C04AX10,G04BE06

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338

MOXISYLYTE price More Price(3)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
American Custom Chemicals Corporation API0008715 MOXISYLYTE 95.00% 54-32-0 5MG $501.04 2021-12-16 Buy
American Custom Chemicals Corporation API0008715 MOXISYLYTE 95.00% 54-32-0 1G $1124.55 2021-12-16 Buy
Crysdot CD12062995 4-(2-(Dimethylamino)ethoxy)-5-isopropyl-2-methylphenylacetate 95+% 54-32-0 1g $608 2021-12-16 Buy
Product number Packaging Price Buy
API0008715 5MG $501.04 Buy
API0008715 1G $1124.55 Buy
CD12062995 1g $608 Buy

MOXISYLYTE Chemical Properties,Uses,Production

Originator

Carlytene,Dedieu,France,1962

Uses

alpha-adrenergic blocker

Definition

ChEBI: Acetic acid [4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] ester is a monoterpenoid.

Manufacturing Process

A hydrochloric acid solution of 100 g of thymol in alcohol is reacted with 72 g of sodium nitrite, the nitrosothymol (Organic Syntheses 6, New York, 1926, p. 92) thus obtained is introduced into ammonia, and is reduced by the introduction of hydrogen sulfide to 4-aminothymol (Organic Syntheses Coll. Vol. 1, New York, 1932, p. 458). 133.3 g of this 4-aminothymol are mixed with 67 g of sodium acetate, 107 g of glacial acetic acid and 80 g of acetic acid anhydride to form 4-acetaminothymol (Plancher, Gazzetta Chimica Italiana 25, II, p. 388). 156 parts by weight of this last formed substance dissolved in 600 cc of alcohol are added to a solution of 17.6 parts by weight of sodium in 600cc of alcohol, the mixture being boiled under reflux for some time with 82 g of dimethylaminoethyl chloride. The reaction product is treated with water, and neutralized with hydrochloric acid using acid Congo reagent indicator, and the alcohol is distilled off in vacuo. The base liberated by alkali is dissolved in ether. By evaporating the ether solution the dimethylaminoethyl ether of the 4-acetaminothymol is obtained as a brownish-yellow oil. After some time this oil solidifies in a crystalline state.
100 g of this base are dissolved in a mixture of 300 cc of concentrated hydrochloric acid (density 1.19) and 400 cc of water, and the solution is boiled for one hour under a reflux condenser. Thereupon it is made alkaline, extracted with ether, and the ether is distilled off. 23.6 g of the 4- aminothymoxyethyldimethylamine thus obtained are diazotized in the presence of sulfuric acid at a temperature not exceeding 0°C using a solution of 7.2 g of sodium nitrite in 70 cc of water, and the diazo compound is heated to boiling point after the addition of 1 g of copper sulfate, until no further gas is evolved. It is then made alkaline, and carbon dioxide is introduced. The base is precipitated first in an oily state, and soon becomes crystalline. The 4- oxythymoxyethyldimethylamine forms a neutral hydrochloride which is readily soluble in water, and has a melting point of 174°C to 175.5°C.
36.8 g of 4-oxythymoxyethyldimethylamine are boiled for one hour on a water bath with 160 cc of acetic anhydride and 17.5 cc of pyridine. After this period, the solution is diluted with water, made alkaline, and the base is extracted with ether and the ether distilled off. With acids, the base obtained forms crystalline salts which are readily soluble in water. The hydrochloride melts between 208°C and 210°C.

Therapeutic Function

Vasodilator

World Health Organization (WHO)

Moxisylyte was introduced in the late 1980s. It belongs to the group of a-adrenergic blocking agents. In France it is indicated for the treatment of manifestations of benign prostatic hypertrophy. It is also marketed in the UK at lower dosages for the treatment of peripheral vascular disorders (Raynaud's disease).

MOXISYLYTE Preparation Products And Raw materials

Global( 18)Suppliers
Supplier Tel Email Country ProdList Advantage
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 27945 58
AFINE CHEMICALS LIMITED
0571-85134551 18958018566; info@afinechem.com China 15377 58
Shaanxi Didu New Materials Co. Ltd
+86-89586680 +86-13289823923 1026@dideu.com China 9020 58
Nanjing Sunlida Biological Technology Co., Ltd. 025-57798810 sales@sunlidabio.com China 3750 55
Shanghai TaoSu Biochemical Technology Co., Ltd. 021-33632979 info@tsbiochem.com China 8073 58
Raw material medicin reagent co.,Ltd sales@njromanme.com China 4534 58
Aikon International Limited 025-58851090 13611564524 lwan@aikonchem.com China 15952 58
Wuhan Yanzhe Technology Co., Ltd 15527250409 wenhaotian12@163.com China 4576 58
Shaanxi DIDU pharmaceutical and Chemical Co., Ltd 17691182729 18161915376 1046@dideu.com China 10011 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725 malulu@leyan.com China 40041 58

View Lastest Price from MOXISYLYTE manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
MOXISYLYTE USP/EP/BP pictures 2021-07-28 MOXISYLYTE USP/EP/BP
54-32-0
US $1.10 / g 1g 99.9% 100 Tons min Dideu Industries Group Limited
moxisylyte opilon sympal thymoxamine timoxamina 4-(2-dimethylaminoethoxy)-5-isopropyl-2-methylphenyl acetate Moxisylyte (base and/or unspecified salts) Vasoklin [4-(2-dimethylaminoethyloxy)-2-methyl-5-propan-2-ylphenyl] acetate [4-(2-dimethylaminoethyloxy)-2-methyl-5-propan-2-yl-phenyl] ethanoate acetic acid [4-(2-dimethylaminoethyloxy)-5-isopropyl-2-methyl-phenyl] ester 2-(4-(2-(diMethylaMino)ethoxy)-5-isopropyl-2-Methylphenyl)acetic acid 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-phenoacetate(ester 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)phenolacetate(ester) 5-(2-(dimethylamino)ethoxy)-carvacroacetate(ester) arlytene moxilite moxisylyt THYMOXAMINE HCL Phenol, 4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, 1-acetate MOXISYLYTE USP/EP/BP 54-32-0 C16H25NO3